ARTL

Artelo Biosciences, INC.

Insider trading activity for Artelo Biosciences, INC., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 31 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jul 17	Matsui Connie	Director	AGRANT◆	136	—	—	—	Open the original filing on SEC.gov
Jul 17	Blayney Douglas	Director	AGRANT◆	136	—	—	—	Open the original filing on SEC.gov
Jul 17	Reyes Gregory	Director	AGRANT◆	136	—	—	—	Open the original filing on SEC.gov
Jul 17	Emanuele Robert Martin	Director	AGRANT◷◆	136	—	—	—	Open the original filing on SEC.gov
Jul 17	Kelly Steven	Director	AGRANT◆	136	—	—	—	Open the original filing on SEC.gov
Jul 17	Favorito Tamara A	Director	AGRANT◆	136	—	—	—	Open the original filing on SEC.gov
Jan 30	Matsui Connie	Director	AGRANT◆	292	—	—	—	Open the original filing on SEC.gov
Jan 30	Blayney Douglas	Director	AGRANT◆	292	—	—	—	Open the original filing on SEC.gov
Jan 30	Emanuele Robert Martin	Director	AGRANT◆	292	—	—	—	Open the original filing on SEC.gov
Jan 30	Kelly Steven	Director	AGRANT◆	292	—	—	—	Open the original filing on SEC.gov
Jan 30	Favorito Tamara A	Director	AGRANT◆	292	—	—	—	Open the original filing on SEC.gov
Jan 30	Reyes Gregory	Director	AGRANT◆	292	—	—	—	Open the original filing on SEC.gov
Jan 29	Spring Mark Edward	Chief Financial Officer	AGRANT◆	36,391	—	—	—	Open the original filing on SEC.gov
Jan 29	Gorgas Gregory D.	Pres, CEO, CFO, Treas &…	AGRANT◆	154,713	—	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Matsui Connie	Director	CCONV◆	—	$110,843.00	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Matsui Connie	Director	CCONV◆	70,376	—	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Matsui Connie	Director	CCONV◆	38,346	—	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Matsui Connie	Director	CCONV◆	—	$140,000.00	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Favorito Tamara A	Director	CCONV◆	—	$19,793.00	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Favorito Tamara A	Director	CCONV◆	12,566	—	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Favorito Tamara A	Director	CCONV◆	6,846	—	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Favorito Tamara A	Director	CCONV◆	—	$25,000.00	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Gorgas Gregory D.	President, CEO,…	CCONV◆	—	$27,710.00	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Gorgas Gregory D.	President, CEO,…	CCONV◆	17,952	—	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Gorgas Gregory D.	President, CEO,…	CCONV◆	9,586	—	—	—	Open the original filing on SEC.gov
Oct 28, 2025	Gorgas Gregory D.	President, CEO,…	CCONV◆	—	$35,000.00	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Gorgas Gregory D.	President, CEO, CFO,…	AGRANT◆	20,000	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Gorgas Gregory D.	President, CEO, CFO,…	AGRANT◆	20,393	—	—	—	Open the original filing on SEC.gov
May 1, 2025	Favorito Tamara A	Director	PDBUY◆	—	$25,000.00	—	—	Open the original filing on SEC.gov
May 1, 2025	Matsui Connie	Director	PDBUY◆	—	$140,000.00	—	—	Open the original filing on SEC.gov
May 1, 2025	Gorgas Gregory D.	Pres, CEO, CFO, Treas &…	PDBUY◆	—	$35,000.00	—	—	Open the original filing on SEC.gov

AGRANT◆—

Matsui Connie · DirectorJul 17

136 sh

AGRANT◆—

Blayney Douglas · DirectorJul 17

136 sh

AGRANT◆—

Reyes Gregory · DirectorJul 17

136 sh

AGRANT◷◆—

Emanuele Robert Martin · DirectorJul 17

136 sh

AGRANT◆—

Kelly Steven · DirectorJul 17

136 sh

AGRANT◆—

Favorito Tamara A · DirectorJul 17

136 sh

AGRANT◆—

Matsui Connie · DirectorJan 30

292 sh

AGRANT◆—

Blayney Douglas · DirectorJan 30

292 sh

AGRANT◆—

Emanuele Robert Martin · DirectorJan 30

292 sh

AGRANT◆—

Kelly Steven · DirectorJan 30

292 sh

AGRANT◆—

Favorito Tamara A · DirectorJan 30

292 sh

AGRANT◆—

Reyes Gregory · DirectorJan 30

292 sh

AGRANT◆—

Spring Mark Edward · Chief Financial…Jan 29

36,391 sh

AGRANT◆—

Gorgas Gregory D. · Pres, CEO, CFO,…Jan 29

154,713 sh

CCONV◆—

Matsui Connie · DirectorOct 28, 2025

— sh @ $110,843.00

CCONV◆—

Matsui Connie · DirectorOct 28, 2025

70,376 sh

CCONV◆—

Matsui Connie · DirectorOct 28, 2025

38,346 sh

CCONV◆—

Matsui Connie · DirectorOct 28, 2025

— sh @ $140,000.00

CCONV◆—

Favorito Tamara A · DirectorOct 28, 2025

— sh @ $19,793.00

CCONV◆—

Favorito Tamara A · DirectorOct 28, 2025

12,566 sh

CCONV◆—

Favorito Tamara A · DirectorOct 28, 2025

6,846 sh

CCONV◆—

Favorito Tamara A · DirectorOct 28, 2025

— sh @ $25,000.00

CCONV◆—

Gorgas Gregory D. · President, CEO,…Oct 28, 2025

— sh @ $27,710.00

CCONV◆—

Gorgas Gregory D. · President, CEO,…Oct 28, 2025

17,952 sh

CCONV◆—

Gorgas Gregory D. · President, CEO,…Oct 28, 2025

9,586 sh

CCONV◆—

Gorgas Gregory D. · President, CEO,…Oct 28, 2025

— sh @ $35,000.00

AGRANT◆—

Gorgas Gregory D. · President, CEO,…Jul 2, 2025

20,000 sh

AGRANT◆—

Gorgas Gregory D. · President, CEO,…Jul 2, 2025

20,393 sh

PDBUY◆—

Favorito Tamara A · DirectorMay 1, 2025

— sh @ $25,000.00

PDBUY◆—

Matsui Connie · DirectorMay 1, 2025

— sh @ $140,000.00

PDBUY◆—

Gorgas Gregory D. · Pres, CEO, CFO,…May 1, 2025

— sh @ $35,000.00

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 21 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →